Literature DB >> 8354309

Testing susceptibility of fungi to fluconazole.

M Scheven.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8354309     DOI： 10.1007/bf01964441

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   3.267


× No keyword cloud information.
  4 in total

Review 1.  Susceptibility of Candida albicans and other yeasts to fluconazole: relation between in vitro and in vivo studies.

Authors:  J N Galgiani
Journal:  Rev Infect Dis       Date:  1990 Mar-Apr

Review 2.  Testing of organisms for susceptibility to triazoles: is it justified?

Authors:  G S Kobayashi; E D Spitzer
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-05       Impact factor: 3.267

Review 3.  Fluconazole and other azoles: translation of in vitro activity to in vivo and clinical efficacy.

Authors:  P F Troke; R J Andrews; G W Pye; K Richardson
Journal:  Rev Infect Dis       Date:  1990 Mar-Apr

4.  Correlation of susceptibility test results in vitro with response in vivo: ketoconazole therapy in a systemic candidiasis model.

Authors:  A Polak; F C Odds; E Lüdin; H J Scholer
Journal:  Chemotherapy       Date:  1985       Impact factor: 2.544
  4 in total
  3 in total

1.  Selection of Candida glabrata strains with reduced susceptibility to azoles in four liver transplant patients with invasive candidiasis.

Authors:  J Fortún; A López-San Román; J J Velasco; A Sánchez-Sousa; E de Vicente; J Nuño; C Quereda; R Bárcena; G Monge; A Candela; A Honrubia; A Guerrero
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-04       Impact factor: 3.267

2.  Fluconazole and voriconazole multidisk testing of Candida species for disk test calibration and MIC estimation.

Authors:  G Kronvall; I Karlsson
Journal:  J Clin Microbiol       Date:  2001-04       Impact factor: 5.948

3.  Antifungal susceptibility testing of yeasts: evaluation of technical variables for test automation.

Authors:  F C Odds; L Vranckx; F Woestenborghs
Journal:  Antimicrob Agents Chemother       Date:  1995-09       Impact factor: 5.191
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.